Shared Decision Making on Care Pathways and CAMs: A Pilot Study

Breast Cancer Clinical Trial

Official title: Shared Decision Making on Care Pathways and CAMs: A Pilot Study

Status Recruiting

Clinical Trial Summary

Shared Decision Making on Care Pathways and alternative and complementary medicine (CAMs) : A Pilot Study.

Study whose aim is to evaluate the feasibility of a study proposing a therapeutic education consultation leaning on the usual care pathway by estimating the recruitment capacity over 4 months as well as the acceptance rate of the study among patients diagnosed with breast cancer.

Clinical Trial Description

The use of alternative and complementary medicine (CAMs) has been steadily increasing for several years. Certain populations are more likely than others to use this type of care, including breast cancer patients, for whom the rate of use is close to 90%. However, these populations are those for whom the risks associated with this type of care are the highest. In addition, patients rarely discuss alternative and complementary medicine (CAMs) with conventional care teams. As a result, patients often place unreasonable expectations on alternative and complementary medicine (CAMs) and at the same time put themselves in risky situations.

The aim of this project is to help breast cancer patients better orient themselves in their care pathway and in particular with regard to the plethora of alternative and complementary medicine (CAMs) available. They could therefore make an informed decision to seek (or not) treatment. In order to reach a shared decision, a consultation will be offered to patients with the objective of discussing their past recourse, their knowledge of the care pathway, their fears and their aspirations with regard to alternative and complementary medicine (CAM). Epistemological concepts (self-efficacy, placebo, benefit-risk ratio, etc.) will be discussed in order to allow these elements to be transposed throughout their care.

The impact of this consultation on compliance with conventional treatment, satisfaction with the treatment as a whole and communication with the rest of the health care team will be evaluated. A before/after methodology will first allow us to evaluate the values taken by our judgement criteria in the usual care pathway and then in the innovative care pathway proposed by the intervention. This study will allow us to establish the feasibility of a future research project of larger scale. ;

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms
• Feasibility Study
• Newly Diagnosed
• Non-metastatic

• NCT number: NCT05388734
• Study type: Interventional
• Source: University Hospital, Grenoble
• Contact: NICOLAS PINSAULT
• Phone: 0476765040
• Email: Npinsault@chu-grenoble.fr
• Status: Recruiting
• Phase: N/A
• Start date: September 28, 2022
• Completion date: August 2024